AdvancedAdvT (LON:ADVT) Given "Buy" Rating at Shore Capital

Key Points

• AdvancedAdvT's stock has been given a "buy" rating by Shore Capital, with a target price of GBX 240, suggesting a potential upside of 31.96%.
• The company's stock experienced a decline of 4.3%, opening at GBX 181.88, with a 12-month price range between GBX 120.25 and GBX 215.
• AdvancedAdvT has a market cap of £248.13 million and reported earnings of GBX 8 per share, along with a net margin of 30.56% as of its last earnings report.

AdvancedAdvT (LON:ADVT - Get Free Report)'s stock had its "buy" rating reissued by equities researchers at Shore Capital in a research report issued to clients and investors on Thursday,Digital Look reports. They presently have a GBX 240 target price on the stock. Shore Capital's target price would indicate a potential upside of 31.96% from the company's previous close.

AdvancedAdvT Stock Down 4.3%

ADVT opened at GBX 181.88 on Thursday. AdvancedAdvT has a 12 month low of GBX 120.25 and a 12 month high of GBX 215. The company has a fifty day simple moving average of GBX 194.15 and a 200 day simple moving average of GBX 171.97. The stock has a market cap of £248.13 million, a P/E ratio of 2,273.50 and a beta of 0.52.

AdvancedAdvT (LON:ADVT - Get Free Report) last released its earnings results on Monday, June 30th. The company reported GBX 8 earnings per share (EPS) for the quarter. AdvancedAdvT had a return on equity of 1.17% and a net margin of 30.56%.

About AdvancedAdvT

AdvancedAdvT Limited does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, share or debt purchase, reorganization, or similar business combination with one or more businesses. The company was formerly known as Marwyn Acquisition Company I Limited and changed its name to AdvancedAdvT Limited in March 2021.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.